Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities ...

Touch Bionics, the maker of this mechanical wonder, calls it the i-limb. The name represents more than marketing. Improved software, longer-lasting batteries and smaller, more power-efficient ...

IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (BBNX), a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its ...

IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...

Net sales of $27.3 million, up 63% compared to $16.7 million in the third quarter of 2024. Durable Medical Equipment (DME) channel net sales of $21.0 million, up 45% compared to $14.5 million in the ...

In recent years, the field of prosthetics has seen remarkable innovations, one of which is the development of pain-sensing bionic limbs. By emulating the natural functionality and pain perception of ...

VALENCIA, CA / ACCESS Newswire / April 14, 2026 / Advanced Bionics (AB), a global leader in cochlear implant technology, ...

Beta Bionics, a pioneering medical device company, has announced its most impressive quarterly earnings to date. In the first ...

Beta Bionics, Inc. (BBNX) delivered earnings and revenue surprises of +8.24% and -0.45%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?